DK170840B1 - Tricycliske lactamer indeholdende en benzazepingruppe, lægemiddel indeholdende sådanne lactamer samt anvendelse deraf til fremstilling af et lægemiddel til behandling af hypertension - Google Patents

Tricycliske lactamer indeholdende en benzazepingruppe, lægemiddel indeholdende sådanne lactamer samt anvendelse deraf til fremstilling af et lægemiddel til behandling af hypertension Download PDF

Info

Publication number
DK170840B1
DK170840B1 DK300487A DK300487A DK170840B1 DK 170840 B1 DK170840 B1 DK 170840B1 DK 300487 A DK300487 A DK 300487A DK 300487 A DK300487 A DK 300487A DK 170840 B1 DK170840 B1 DK 170840B1
Authority
DK
Denmark
Prior art keywords
acid
mmol
solution
lactams
formula
Prior art date
Application number
DK300487A
Other languages
Danish (da)
English (en)
Other versions
DK300487D0 (da
DK300487A (da
Inventor
Gary A Flynn
Douglas W Beight
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of DK300487D0 publication Critical patent/DK300487D0/da
Publication of DK300487A publication Critical patent/DK300487A/da
Application granted granted Critical
Publication of DK170840B1 publication Critical patent/DK170840B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
DK300487A 1986-06-13 1987-06-12 Tricycliske lactamer indeholdende en benzazepingruppe, lægemiddel indeholdende sådanne lactamer samt anvendelse deraf til fremstilling af et lægemiddel til behandling af hypertension DK170840B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US87375486A 1986-06-13 1986-06-13
US87375486 1986-06-13
AT269187 1987-10-12
AT0269187A AT398425B (de) 1986-06-13 1987-10-12 Neue tricyclische lactame

Publications (3)

Publication Number Publication Date
DK300487D0 DK300487D0 (da) 1987-06-12
DK300487A DK300487A (da) 1987-12-14
DK170840B1 true DK170840B1 (da) 1996-02-05

Family

ID=25598925

Family Applications (1)

Application Number Title Priority Date Filing Date
DK300487A DK170840B1 (da) 1986-06-13 1987-06-12 Tricycliske lactamer indeholdende en benzazepingruppe, lægemiddel indeholdende sådanne lactamer samt anvendelse deraf til fremstilling af et lægemiddel til behandling af hypertension

Country Status (12)

Country Link
EP (1) EP0249223B1 (sv)
JP (1) JP2542213B2 (sv)
KR (1) KR950014572B1 (sv)
AR (1) AR247213A1 (sv)
AT (1) AT398425B (sv)
AU (1) AU601433B2 (sv)
CA (1) CA1337654C (sv)
DK (1) DK170840B1 (sv)
ES (1) ES2044870T3 (sv)
GR (1) GR3006802T3 (sv)
IE (1) IE61476B1 (sv)
ZA (1) ZA874107B (sv)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4824832A (en) * 1987-12-30 1989-04-25 Merrell Dow Pharmaceuticals Inc. Sulfhydryl containing tricyclic lactams and their pharmacological methods of use
CA2053340C (en) * 1990-10-18 2002-04-02 Timothy P. Burkholder Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
US5208230A (en) * 1990-12-21 1993-05-04 Merrell Dow Pharmaceuticals Amino and nitro containing tricyclic compounds useful as inhibitors of ACE
CA2057786C (en) * 1990-12-21 2002-06-18 Gary A. Flynn Amino and nitro containing tricyclic compounds useful as inhibitors or ace
ZA927211B (en) * 1991-09-27 1993-03-24 Merrell Dow Pharma Novel carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE.
DE69220744T2 (de) * 1991-09-27 1997-11-13 Merrell Pharma Inc 2-Substituierte Indan-2-Mercaptoacetylamid-Verbindungen mit Enkephalinase und ACE-Hemmwirkung
US5457196A (en) * 1991-09-27 1995-10-10 Merrell Dow Pharmaceuticals Inc. 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE
AU657793B2 (en) * 1991-09-27 1995-03-23 Merrell Pharmaceuticals Inc. Novel 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE
US5455242A (en) * 1991-09-27 1995-10-03 Merrell Dow Pharmaceuticals Inc. Carboxyalkyl tricyclic derivatives useful as inhibitors of enkephalinase and ace
DK0625987T3 (da) * 1992-02-14 1999-01-11 Merrell Pharma Inc Aminoacetylmercaptoacetylamid-derivater, der kan anvendes som inhibitorer af enkephalinase og ACE
US5552397A (en) * 1992-05-18 1996-09-03 E. R. Squibb & Sons, Inc. Substituted azepinone dual inhibitors of angiotensin converting enzyme and neutral exdopeptidase
ATE182892T1 (de) * 1992-05-15 1999-08-15 Merrell Pharma Inc Mercaptoacetylamide von pyridazo(1,2-a>(1,2>- diazepin -derivaten als eukephalinase und ace- inhibitoren
US5238932A (en) * 1992-05-20 1993-08-24 Merrell Dow Pharmaceuticals Inc. Mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase
AU673857B2 (en) * 1992-10-30 1996-11-28 Aventisub Ii Inc. Mercaptoacetylamide bicyclic lactam derivatives
US5654294A (en) * 1993-05-13 1997-08-05 Bristol-Myers Squibb Spiro lactam dual action inhibitors
US5362727A (en) * 1993-07-26 1994-11-08 Bristol-Myers Squibb Substituted azepino[2,1-a]isoquinoline compounds
ES2112034T3 (es) * 1993-11-19 1998-03-16 Merrell Pharma Inc Nuevo procedimiento de preparacion del ester de metilo del acido (s)-1-(2(s)-(1,3-dihidro-1,3-dioxo-isoindol-2-il)-1-oxo-3-fenilpropil)-1,2,3,4-tetrahidro-2-piridino-carboxilico e intermediarios de este compuesto.
US5530013A (en) * 1994-02-14 1996-06-25 American Home Products Corporation Venlafaxine in the inducement of cognition enhancement
AU689192B2 (en) * 1994-02-14 1998-03-26 Merrell Pharmaceuticals Inc. Novel 2-substituted indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
ATE177098T1 (de) * 1994-02-14 1999-03-15 Merrell Pharma Inc Mercaptoacetylamid disulfidderivate als enkephalinase und ace inhibitoren
CA2183313C (en) * 1994-02-14 2001-01-02 Gary A. Flynn Novel indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase
PT750631E (pt) * 1994-02-14 2000-07-31 Merrell Pharma Inc Novos derivados de dissulfureto de mercapto-aacetilamido-1,3,4,5-tetra-hidro-benzo¬c)azepin-3-ona uteis como inibidores de encefalinase e ace
US5484783A (en) * 1994-03-24 1996-01-16 Merrell Dow Pharmaceuticals Inc. Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide and benzazapine derivatives
DE69514912T2 (de) * 1994-03-24 2000-10-05 Merrell Pharmaceuticals Inc., Cincinnati Hypocholesterolemische, antiatherosklerotische und hypotriglyceridemische verwendung von aminoacetylmercapto derivaten
US6013645A (en) * 1994-03-24 2000-01-11 Hoechst Marion Roussel, Inc. Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide disulfide derivatives
JP3658408B2 (ja) * 1994-12-21 2005-06-08 アベンティス・ファーマスーティカルズ・インコーポレイテッド エンケファリナーゼおよびアンギオテンシン変換酵素の阻害剤の中間体を製造する新規な方法およびその中間体
US5641880A (en) * 1994-12-21 1997-06-24 Hoechst Marion Roussel, Inc. Processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof
US5587375A (en) * 1995-02-17 1996-12-24 Bristol-Myers Squibb Company Azepinone compounds useful in the inhibition of ACE and NEP
US5877313A (en) * 1995-05-17 1999-03-02 Bristol-Myers Squibb Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP
US5650408A (en) * 1995-06-07 1997-07-22 Karanewsky; Donald S. Thiazolo benzazepine containing dual action inhibitors
US5635504A (en) * 1995-06-07 1997-06-03 Bristol-Myers Squibb Co. Diazepine containing dual action inhibitors
GB0119305D0 (en) 2001-04-12 2001-10-03 Aventis Pharma Gmbh Mercaptoacetylamide derivatives,a process for their preparation and their use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0107095B1 (en) * 1982-09-30 1987-09-09 Merck & Co. Inc. 1-n-alkylcarboxy-benzofused lactams useful as antihypertensive agents
EP0166357A3 (en) * 1984-06-26 1988-10-26 Merck & Co. Inc. Benzofused lactams and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
AR247213A1 (es) 1994-11-30
ATA269187A (de) 1994-04-15
KR880000399A (ko) 1988-03-25
JP2542213B2 (ja) 1996-10-09
IE61476B1 (en) 1994-11-02
EP0249223A2 (en) 1987-12-16
AU601433B2 (en) 1990-09-13
JPS62298591A (ja) 1987-12-25
CA1337654C (en) 1995-11-28
GR3006802T3 (sv) 1993-06-30
DK300487D0 (da) 1987-06-12
EP0249223B1 (en) 1992-10-14
ZA874107B (sv) 1987-12-09
EP0249223A3 (en) 1989-01-25
AT398425B (de) 1994-12-27
KR950014572B1 (ko) 1995-12-08
ES2044870T3 (es) 1994-01-16
DK300487A (da) 1987-12-14
IE871547L (en) 1987-12-13
AU7402287A (en) 1987-12-17

Similar Documents

Publication Publication Date Title
DK170840B1 (da) Tricycliske lactamer indeholdende en benzazepingruppe, lægemiddel indeholdende sådanne lactamer samt anvendelse deraf til fremstilling af et lægemiddel til behandling af hypertension
US4973585A (en) Tricyclic lactams active as antihypertensive agents
NO872462L (no) Fremgangsmaate ved fremstilling av nye, antihypertensive midler.
JP3295848B2 (ja) ４−メルカプトアセチルアミノ−［２］ベンズアゼピノン（３）誘導体及びエンケファリナーゼ阻害剤としての用途
KR900001191B1 (ko) 3-아미노-[1]벤즈아제핀-2-온-1-알카노산의 제조방법
US4584294A (en) Fused tricyclic lactams as angiotensin converting enzyme inhibitors and as antihypertensive agents
EP0135349B1 (en) Condensed seven-membered ring compounds and their production and use
JP2001226269A (ja) メラニン凝集ホルモン拮抗剤
JP3495376B2 (ja) スピロ環メタロプロテアーゼ阻害剤
CZ289245B6 (cs) Deriváty benzazepin-, benzoxazepin- a benzothiazepin-N-octové kyseliny, způsob jejich výroby a léčivo, obsahující tyto sloučeniny
HU217078B (hu) Eljárás tio- és karbonil-amino-csoportot tartalmazó oldallánccal helyettesített heterociklusos karbonsavszármazékok és az ezeket tartalmazó gyógyszerkészítmények előállítására
HU199842B (en) Process for producing pyridazodiazepines and pharmaceutical compositions comprising same
SU1115668A3 (ru) Способ получени производных пролина
EP0747393A1 (en) Thiazolo benzazepine containing dual action inhibitors
NZ206236A (en) 3-(4-(1-carboxyalk-3-yl)-alpha-aminoalkanoyl)-3-azatricyclo-(5.2.1.0 2-6 ) decan-4-ylcarboxylic acids
JP3563738B2 (ja) アミノ酸誘導体
HUT71246A (en) Mercaptoacylamine-substituted benzazepine derivatives condensed with heterocycles and process for preparing them
EP0399556A1 (en) Amino-substituted heterocycles as renin inhibitors
US20040063699A1 (en) Gpr14 antagonist
EP0166353B1 (en) Benzofused lactams useful as antihypertensive agents and as cholecystokinin antagonists
DE3782190T2 (de) Antihypertensives mittel.
KR100603798B1 (ko) 아미노 안트라사이클리논 유도체 및 이를 포함하는 약제학적 조성물
KR840001036B1 (ko) 7, 8-디하이드록시-1-(설파밀페닐)-2, 3, 4, 5-테트라하이드로-1h-3-벤자제핀 유도체의 제조방법
AU680512B2 (en) Amino acid derivative
JP2002097142A (ja) Ｇｐｒ１４拮抗剤

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired